[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Ampio Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ampio Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Amrutanjan Health Care Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amrutanjan Health Care Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AmStem Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AmStem Corp Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Amsterdam Molecular Therapeutics (AMT) Holding N.V. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amsterdam Molecular Therapeutics (AMT) Holding N.V. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Amylin Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amylin Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Anacor Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anacor Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Anadys Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anadys Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Analytik Jena AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Analytik Jena AG Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Anavex Life Sciences Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anavex Life Sciences Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Angel Biotechnology Holdings PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Angel Biotechnology Holdings PLC Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AnGes MG Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AnGes MG Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AngioGenex, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AngioGenex, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Angiotech Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Angiotech Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Anhui Anke Biotechnology (Group) Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anhui Anke Biotechnology (Group) Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Anhui Fengyuan Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anhui Fengyuan Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Ankur Drugs & Pharma Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ankur Drugs & Pharma Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Anthera Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anthera Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Anticus International Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anticus International Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Antigenics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Antigenics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Antisense Therapeutics Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Antisense Therapeutics Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Antisoma plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Antisoma plc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Anuh Pharma Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anuh Pharma Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Anxin-China Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anxin-China Holdings Limited Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aoxing Pharmaceutical Company, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aoxing Pharmaceutical Company, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AP Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AP Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Apeloa Company Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Apeloa Company Limited Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Apex Biotechnology Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Apex Biotechnology Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Apex Healthcare Bhd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Apex Healthcare Bhd Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aphton Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aphton Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Apogee Technology, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Apogee Technology, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Apollo Consolidated Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Apollo Consolidated Limited Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aposense Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aposense Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Applied NeuroSolutions Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Applied NeuroSolutions Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Apricus Biosciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Apricus Biosciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aprogenex, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aprogenex, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aqua Bounty Technologies, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aqua Bounty Technologies, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aquamatrix Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aquamatrix Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aquamer Medical Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aquamer Medical Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Arab Pharmaceuticals Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Arab Pharmaceuticals Co. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

ARCA biopharma, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ARCA biopharma, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Ardea Biosciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ardea Biosciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Arena Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Arena Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Argonaut Technologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Argonaut Technologies Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Ariad Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ariad Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Premier Veterinary Group plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Premier Veterinary Group plc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

ArQule Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ArQule Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Array BioPharma, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Array BioPharma, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Arrayit Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Arrayit Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Arrowhead Research Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Arrowhead Research Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Artec, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Artec, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers